Roche NimbleGen Introduces Advanced RNA-Seq Target Enrichment Tools for In-Depth Transcriptome Studies
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applicati…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap RNA Target Enrichment System for RNA-Seq applicati…
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the release of SeqCap EZ Exome Designs for target enrichment of the wheat,…
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its new alpha-2,6-Sialyltransferase for in vitro sialyl…
In a newly created award, pRED's Discovery Oncology unit of Roche (SIX: RO, ROG; OTCQX: RHHBY) in Penzberg, Germany invi…
Roche (SIX: RO, ROG; OTCQX: RHHBY) gab heute die weltweite Markteinführung (außer in den USA) des Elecsys Calcitonin Tes…
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an exclusive…
A team of researchers from Roche (SIX: RO, ROG; OTCQX: RHHBY), including scientists from Roche Pharma Research and Early…
Ein Großteil aller Biotherapeutika wird mit Expressionssystemen aus Bakterien- oder Säugerzellen hergestellt. Während de…
A vast majority of biotherapeutics are manufactured in either bacterial or mammalian expression systems. Metabolite prof…
In einem diese Woche online in der Fachzeitschrift Nature erschienenen Artikel stellt ein internationales Forscherteam d…